Prokidney Corp.

PROK Nasdaq SEC CIK 1850270
Follow Prokidney Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $174K −19.8% vs same quarter last year
Net income −$35.6M −116.1% vs same quarter last year
EPS, diluted -
Operating cash flow −$38.7M −45.3% vs same quarter last year
Revenue by quarter
$76K
$230K
$221K
$217K
$225K
$226K
$150K
$174K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$150M−$100M−$50M$0$50MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$893K−$69M
FY24$76K−$61.2M
FY23$0−$35.5M
FY22$0−$148.1M
FY21-−$55.1M
FY20-−$26.7M
FY19--
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$135.3M
FY24−$155.9M
FY23−$124.3M
FY22−$78.9M
FY21−$55.5M
FY20−$30.6M
FY19-
Returned to shareholdersDividends paid and shares bought back
$0$2.5M$5M$7.5M$10MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearBuybacks
FY25$0
FY24$0
FY23$9.5M
FY22$0
FY21$0
FY20-
FY19-